LWM
HUMA icon

LJI Wealth Management’s Humacyte HUMA Stock Holding History

LJI Wealth Management’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$168K Sell
277,500
-31,000
-10% -$32.2K 0.03% 187
2025
Q4 		$296K Sell
308,500
-7,500
-2% -$10.6K 0.05% 163
2025
Q3 		$550K Buy
316,000
+28,000
+10% +$54.9K 0.1% 81
2025
Q2 		$602K Buy
288,000
+62,000
+27% +$119K 0.1% 78
2025
Q1 		$385K Buy
226,000
+41,000
+22% +$154K 0.08% 107
2024
Q4 		$934K Buy
+185,000
New +$915K 0.18% 50

Other funds holding HUMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AP
Antipodes Partners Royal Exchange, Australia $5.19B AUM 36.17% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

LJI Wealth Management's HUMA Position: Q1 2026 in Review

LJI Wealth Management reduced its Humacyte (HUMA) stake by 10% in Q1 2026, selling an estimated $32.2K and leaving 277,500 shares worth $168K. The position accounts for 0.03% of the portfolio, ranked #187.

LJI Wealth Management first reported a position in HUMA in Q4 2024 and has held it in 6 quarters since. The position peaked at $934K in Q4 2024. 158 funds tracked by Wall St. Rank hold HUMA as of Q1 2026.

  • LJI Wealth Management held 277,500 shares of Humacyte worth $168K as of Q1 2026.
  • LJI Wealth Management sold 31,000 Humacyte shares in Q1 2026, an estimated $32.2K.
  • Humacyte made up 0.03% of LJI Wealth Management's portfolio in Q1 2026, its #187 holding.
  • LJI Wealth Management first reported a position in Humacyte in Q4 2024 and has held it in 6 quarters since.
  • LJI Wealth Management's Humacyte position peaked at $934K in Q4 2024.
  • 158 funds tracked by Wall St. Rank held Humacyte as of Q1 2026.

Based on LJI Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.